Sarepta Therapeutics Inc. (SRPT)
NASDAQ: SRPT
· Real-Time Price · USD
22.20
0.77 (3.59%)
At close: Oct 15, 2025, 3:59 PM
22.28
0.36%
After-hours: Oct 15, 2025, 07:45 PM EDT
Sarepta Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 1.9B | 1.24B | 933.01M | 701.89M |
Cost of Revenue | 319.1M | 150.34M | 139.99M | 97.05M |
Gross Profit | 1.58B | 1.09B | 793.02M | 604.84M |
Operating Income | 218.08M | -267.82M | -536.2M | -449.71M |
Interest Income | 71.77M | 85.97M | 27.72M | 354K |
Pretax Income | 260.77M | -520.1M | -689.96M | -418.95M |
Net Income | 235.24M | -535.98M | -703.49M | -418.78M |
Selling & General & Admin | 557.87M | 481.87M | 451.42M | 282.66M |
Research & Development | 804.52M | 877.39M | 877.09M | 771.18M |
Other Expenses | 2.4M | 1.56M | 714K | 706K |
Operating Expenses | 1.36B | 1.36B | 1.33B | 1.05B |
Interest Expense | 18.39M | 22.01M | 53.25M | 63.52M |
Selling & Marketing Expenses | n/a | 28.6M | 14.6M | 7.7M |
Cost & Expenses | 1.68B | 1.51B | 1.47B | 1.15B |
Income Tax Expense | 25.54M | 15.88M | 13.53M | -168K |
Shares Outstanding (Basic) | 95.08M | 92.4M | 87.56M | 81.26M |
Shares Outstanding (Diluted) | 107.88M | 92.4M | 87.56M | 81.26M |
EPS (Basic) | 2.34 | -5.8 | -8.03 | -5.15 |
EPS (Diluted) | 2.34 | -5.8 | -8.03 | -5.15 |
EBITDA | 333.06M | -439.2M | -582.12M | -306.08M |
EBIT | 279.17M | -498.09M | -636.72M | -355.42M |
Depreciation & Amortization | 53.89M | 58.89M | 54.6M | 49.34M |
Source: Financial Modeling Prep. Financial Sources.